India's two vaccines COVAXIN and ZyCov-D are ready for phase two trial:
"The end is near" India's two COVID-19 vaccines named COVAXIN and ZyCov-D are ready for phase two trial.
Science Ministry's states that a letter by the ICMR (Indian Council for Medical Research) saying August 15 - Independence Day as the target for releasing a novel coronavirus vaccine
The End is Near
Approval for human trials for phase two:
Typically, the first two phases of drug trials test for safety and the third tests the medicine's efficiency. Each phase could take months, or even years, to be completed.
This made-in-India COVID-19 vaccine candidates - COVAXIN and ZyCov-D - marks the "The end is near" for the novel coronavirus pandemic that has infected over 1.13 crore people worldwide and left more than 5.3 lakh dead, the government said last week.
Hundreds of vaccines are at various stages of development around the world to end the coronavirus pandemic.
India being a leading manufacturer of generic medicines, is expected to play a key role in this race. India being among the four worst affected by the COVID-19 virus, with more than 6.9 lakh confirmed cases so far.
WHO said there were more than 100 vaccine candidates in the world currently, of which 11 were in human trials. Along with Indian's two vaccines, COVAXIN and ZyCov-D.
Both Indian vaccines are been approved for Phase II, III trials.